Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
We have a wide range of fun and festive designs to choose from. Fund life changing research while spreading joy this Christmas!
This Christmas, your gift can bring us closer to a cure for type 1 diabetes – and every pound you give to our Christmas Appeal will be doubled.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This event is designed for anyone living with type 1 diabetes who would like to learn more about managing their wellbeing across a variety of contexts.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > New JDRF grant will help early career researchers explore fresh ideas in type 1 diabetes
Dr James Pearson, recipient of the first JDRF Small Grant Award, is a type 1 diabetes researcher at Cardiff University
Cardiff University researcher Dr James Pearson is the first recipient of a new JDRF grant designed to test new ideas and expand the horizons of type 1 diabetes research.
Dr Pearson will explore whether the time of day affects the immune system’s ability to regulate itself.
This knowledge could change our understanding of how to discover and test new ways to cure or prevent type 1 diabetes.
Dr Pearson’s project will be funded through the new JDRF UK Small Grant Awards programme, which offers researchers up to £15,000 to test out new concepts that might otherwise go unexplored.
A further two projects funded by the programme are due to begin in October 2021, based at the University of Exeter.
Type 1 diabetes occurs when the immune system mistakenly attacks insulin-producing cells – meaning that its regulatory mechanisms have failed to work as they should.
That is why many researchers are studying how the immune system regulates itself, as a route to discovering treatments that prevent or cure type 1.
However, if the time of day affects how well the immune system can regulate itself, this suggests that a treatment to boost the immune system’s regulation would be more – or less – effective at different times.
Dr Pearson’s work could therefore have significant implications for researchers testing new molecules in the lab for their potential to become new drugs for curing or preventing type 1 diabetes.
It could also affect the way clinical trials of these potential treatments are run, to maximise their chances of success.
The JDRF UK Small Grant Awards programme was set up to fill a hole in the type 1 diabetes funding pipeline.
Currently, to secure funding for large-scale projects, researchers first need early data to build a strong case for financial support.
However, as university budgets have become more constrained, it has become increasingly challenging to obtain the funding to generate this early data. Some funders offer one-year grant schemes to support new ideas, but the application processes also require extensive pilot data – creating a vicious cycle.
The Small Grant Awards programme enables UK-based early career researchers to apply for up to £15,000 for short-term pilot projects. Applications are assessed by the JDRF UK Scientific Advisory Council, with support from external reviewers, and JDRF will be closely monitoring if these awards lead to type 1 researchers securing further grants to develop these ideas.
Rachel Connor, Director of Research Partnerships at JDRF in the UK, said: “For years, researchers have reported to us that it is extremely difficult to get funding for small-scale pilot projects that enable them to explore new ideas and concepts. This means that these fresh ideas can often go unexplored for years.
“We believe that the Small Grant Awards programme will help early career researchers to overcome this challenge, meaning that more great ideas from type 1 diabetes researchers are picked up for further support.”
The research, which was co-funded by JDRF, reveals that drugs that target the immune system offer very effective and rapid improvements in stabilising blood sugar levels, often within just three months.
The new JDRF-funded clinical trial called SOPHIST will test a drug to help people with type 1 diabetes and heart failure.
Results from a clinical trial called the PROTECT study show that teplizumab can preserve beta cell function in children and adolescents newly diagnosed with type 1 diabetes.